Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 24084328 | HLA-B*44 | viremia | NA | NA | NA | positive | |
| using multivariate statistics, low risk of bk viremia was associated with matching of hla-a2 [hazard ratio (hr) 0.51, 95% confidence interval (ci) 0.28-0.85], hla-b44 (hr 0.31, 95% ci 0.076-0.85) and hla-dr15 (hr 0.35, 95% ci 0.084-0.93) (p < 0.05), whereas high risk of viremia was associated with male gender (hr 2.38, 95% ci 1.46-4.09, p < 0.001). | |||||||
| 24084328 | HLA-DRB1*15 | viremia | NA | NA | NA | positive | |
| using multivariate statistics, low risk of bk viremia was associated with matching of hla-a2 [hazard ratio (hr) 0.51, 95% confidence interval (ci) 0.28-0.85], hla-b44 (hr 0.31, 95% ci 0.076-0.85) and hla-dr15 (hr 0.35, 95% ci 0.084-0.93) (p < 0.05), whereas high risk of viremia was associated with male gender (hr 2.38, 95% ci 1.46-4.09, p < 0.001). | |||||||
| 24134704 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | viremia | NA | NA | NA | negation | |
| association of bk viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor. | |||||||
| 24134704 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | viremia | NA | NA | NA | unclassified | |
| acute rejection episodes and the number of human leukocyte antigen (hla) mismatches were the strongest independent predictors of bk viremia in a multiple logistic model. | |||||||
| 24134704 | HLA (HLA) | viremia | NA | NA | NA | positive | |
| the independent association of hla mismatches with bk viremia suggests impaired polyomavirus immunosurveillance in highly mismatched allografts. | |||||||
| 24686425 | HLA (HLA) | viremia | NA | NA | NA | unclassified | |
| here, bkv viremia in hla-sensitized patients after desensitization with ivig and rituximab was analyzed. | |||||||
| 24917662 | HLA (HLA) | viremia | Canadian | NA | NA | unclassified | |
| hiv serology, hiv-1-specific cell-mediated immune responses, plasma viremia, cell-associated hiv-1 dna and rna, presence of replication-competent hiv-1, and hla genotype were determined for hiv-1-infected children with sustained virologic suppression. | |||||||
| 25111517 | HLA MISMATCHED (HLA-MISMATCHED) | viremia | NA | NA | NA | positive | |
| in univariate analysis, myeloablative conditioning, hla-mismatched donor, cmv viremia and acute gvhd (agvhd) grade 3-4 were significantly associated with the risk of hc. | |||||||
| 25111517 | HLA MISMATCHED (HLA-MISMATCHED) | viremia | NA | NA | NA | unclassified | |
| multivariate analysis confirmed all associating factors identified in univariate analysis except for hla-mismatched donor: myeloablative conditioning (hazard ratio (hr) 2.63, p=0.003), cmv viremia (hr 1.88, p=0.014) and agvhd grade 3-4 (hr 1.71, p=0.029). | |||||||
| 25165115 | HLA (HLA) | viremia | NA | NA | NA | positive | |
| by measuring gamma interferon enzyme-linked immunosorbent spot (elispot) assay responses to a panel of 257 optimally defined epitopes in 341 untreated hiv-infected persons, including persons who spontaneously control viremia, we found that the correlation between hla types and control is mediated by the targeting of specific epitopes. | |||||||
Copyright 2024